Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is $120.35, with a 24-hour trading volume of $1B. The asset's market cap is $297.26B, after moving -0.16% in the last day.
Tokenized Merck & Co Inc is trading at $119.01, with a tokenized market cap of $936.61K and a 24-hour trading volume of $897.74K. The tokenized asset has moved 3.45% in the past 24 hours.